Key result
EuroSCORE II demonstrated good discrimination for predicting in-hospital mortality in Taiwan, but was poorly calibrated for CABG combined, HT, and urgent operations.
Why the study?
EuroSCORE II was derived predominantly from a European cohort, but had not yet been validated in Taiwan.
Does the EuroSCORE II accurately predict in-hospital mortality in adult patients undergoing cardiac surgery in Taiwan?
Cohort (n=2,161)
No
Does the EuroSCORE II accurately predict in-hospital mortality in adult patients undergoing cardiac surgery in Taiwan?
EuroSCORE II provides satisfactory discrimination and calibration for predicting cardiac surgical mortality in Taiwan, though it performs poorly for specific procedures like combined CABG, heart transplantation, and urgent operations.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in Taiwan; leaves open need for local recalibration in combined CABG, transplant, and urgent cases.
The European System for Cardiac Operative Risk Evaluation (EuroSCORE II) is a well-established scoring system for predicting mortality in cardiac surgery. This system was derived predominantly from a European patient cohort; however, no validation of this system has been conducted in Taiwan. We sought to assess the performance of EuroSCORE II at a tertiary centre. The 2161 adult patients receiving cardiac surgery between 2017 and 2020 in our institution were included. Overall, the in-hospital mortality rate was 7.89%. The performance of EuroSCORE II was assessed using the area under the receiver operator curve (AUC) for discrimination and the Hosmer–Lemeshow (H–L) test for calibration. Data were analysed for type of surgery, risk stratification, and status of the operation. EuroSCORE II had good discriminative power (AUC=0.854, 95% Confidence Interval (CI): 0.822–0.885) and good calibration (χ2=5.19, p=0.82) for all types of surgery except ventricular assist devices (AUC=0.618, 95% CI: 0.497–0.738). EuroSCORE II also showed good calibration for most types of surgery except coronary artery bypass surgery (CABG) combined procedure (P=0.033), heart transplantation (HT) (P=0.017), and urgent operation (P=0.041). EuroSCORE II significantly underestimated the risk for CABG combined procedure and urgent operations, and overestimated the risk for HT. EuroSCORE II had satisfactory discrimination and calibration power to predict surgical mortality in Taiwan. However, the model is poorly calibrated for CABG combined procedure, HT, urgent operation, and, likely, lower- and higher-risk patients.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2023) conducted a cohort in Cardiac surgery (n=2,161). EuroSCORE II was evaluated on In-hospital mortality (discrimination and calibration) (AUC 0.854, 95% CI 0.822-0.885, p=0.82). EuroSCORE II demonstrated good discrimination for predicting in-hospital mortality in Taiwan, but was poorly calibrated for CABG combined, HT, and urgent operations.
Synapse has enriched 10 related papers. Consider them for comparative context: